
    
      This was a Randomizedï¼ŒDouble-blind, Placebo-controlled, Single Ascending Dose, Single-center
      Study to Assess the Safety, Tolerability and Pharmacokinetic of Yimitasvir in Healthy Adults
      Subjects

      A total of 56 healthy subjects were divided into 7 groups, with each group consisting of 8
      subjects. Six of the subjects received the investigational drug, and two received placebo.
      All of the subjects received a single dose.
    
  